SCIENTURE HOLDINGS, INC. Repayments of Related Party Debt
SCIENTURE HOLDINGS, INC. (SCNX) reported Repayments of Related Party Debt of $531.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfRelatedPartyDebt · last filed 2026-03-30
- SCIENTURE HOLDINGS, INC. repayments of related party debt for the quarter ending 2021-12-31 was $0.00.
- SCIENTURE HOLDINGS, INC. repayments of related party debt for the quarter ending 2019-12-31 was $222.55K.
- SCIENTURE HOLDINGS, INC. repayments of related party debt for the quarter ending 2018-12-31 was -$100.99K.
- SCIENTURE HOLDINGS, INC. repayments of related party debt for the quarter ending 2018-09-30 was $0.00.
- SCIENTURE HOLDINGS, INC. repayments of related party debt for fiscal 2025 was $531.00K.
- SCIENTURE HOLDINGS, INC. repayments of related party debt for fiscal 2021 was $225.00K.
- SCIENTURE HOLDINGS, INC. repayments of related party debt for fiscal 2019 was $262.55K, a 2344.85% increase from fiscal 2018.
- SCIENTURE HOLDINGS, INC. repayments of related party debt for fiscal 2018 was $10.74K, a 97.52% decline from fiscal 2017.
| Period end | Repayments of Related Party Debt 0 month | Repayments of Related Party Debt 3 month | Repayments of Related Party Debt 6 month | Repayments of Related Party Debt 9 month | Repayments of Related Party Debt 12 month | Repayments of Related Party Debt 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $531.00K 10-K · filed 2026-03-30 | |||||
| 2023-04-13 | $550.00K 10-Q · filed 2024-06-26 | |||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $225.00K 10-K · filed 2023-03-27 | ||||
| 2021-09-30 | $225.00K 10-Q · filed 2022-11-07 | |||||
| 2019-12-31 | $222.55K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $262.55K 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | $40.00K 10-Q · filed 2020-10-26 | |||||
| 2018-12-31 | -$100.99K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$100.99K derived: sum of 2 quarters · filed 2020-03-30 | $10.74K 10-K · filed 2020-03-30 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-28 | $111.72K 10-Q · filed 2019-10-28 | ||||
| 2018-06-30 | $111.72K 10-Q · filed 2019-07-26 | |||||
| 2017-12-31 | $432.69K 10-K · filed 2019-03-22 | |||||
| 2017-03-31 | -$46.65K 10-Q · filed 2017-05-15 | |||||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-15 | $0.00 derived: sum of 2 quarters · filed 2017-05-15 | $0.00 derived: sum of 3 quarters · filed 2017-05-15 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $0.00 derived: sum of 2 quarters · filed 2016-03-28 | $0.00 10-K · filed 2016-03-28 | |||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $0.00 10-Q · filed 2015-11-02 | ||||
| 2015-06-30 | $0.00 10-Q · filed 2015-07-30 | |||||
| 2014-12-31 | $211.28K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $148.53K derived: sum of 2 quarters · filed 2016-03-28 | $65.75K derived: sum of 3 quarters · filed 2016-03-28 | $105.64K 10-K · filed 2016-03-28 | -$105.64K 10-K · filed 2015-03-23 | |
| 2014-09-30 | -$62.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | -$145.53K derived: sum of 2 quarters · filed 2015-11-02 | -$105.64K 10-Q · filed 2015-11-02 | |||
| 2014-06-30 | -$82.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | -$42.89K 10-Q · filed 2015-07-30 | ||||
| 2014-03-31 | $39.89K 10-Q · filed 2015-05-04 | |||||
| 2013-09-30 | $133.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $133.13K 10-Q · filed 2014-10-30 | ||||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |